Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
JPMorgan Ultra-Short Income ETF
JPST
$40.8B
| $814K | ﹤0.01% |
+16,203
| New | +$813K |
|
1677
Coherent
COHR
$53.9B
| $814K | ﹤0.01% |
18,691
-14,600
| -44% | -$526K |
|
1678
PagerDuty
PD
$956M
| $813K | ﹤0.01% |
35,118
-155,449
| -82% | -$3.37M |
|
1679
Nektar Therapeutics
NKTR
$2.52B
| $811K | ﹤0.01% |
95,703
-148,715
| -61% | -$1.13M |
|
|
PCH
1680
DELISTED
PotlatchDeltic
PCH
| $810K | ﹤0.01% |
16,504
-4,142
| -20% | -$190K |
|
1681
U-Haul Holding Co Series N
UHAL.B
$12.2B
| $806K | ﹤0.01% |
11,448
-41,151
| -78% | -$2.24M |
|
1682
Western Digital
WDC
$157B
| $805K | ﹤0.01% |
20,335
+6,989
| +52% | +$245K |
|
|
CTLP
1683
DELISTED
Cantaloupe
CTLP
| $803K | ﹤0.01% |
108,410
+87,020
| +407% | +$601K |
|
1684
Knowles
KN
$2.78B
| $802K | ﹤0.01% |
44,787
-12,363
| -22% | -$192K |
|
1685
RLX Technology
RLX
$2.21B
| $797K | ﹤0.01% |
398,624
-14,819
| -4% | -$27.6K |
|
|
CIVI
1686
DELISTED
Civitas Resources
CIVI
| $796K | ﹤0.01% |
11,636
-53,441
| -82% | -$3.83M |
|
1687
PTC Therapeutics
PTCT
$5.93B
| $794K | ﹤0.01% |
28,823
-81,578
| -74% | -$1.87M |
|
1688
Arcosa
ACA
$7.13B
| $794K | ﹤0.01% |
9,608
-1,005
| -9% | -$73.8K |
|
1689
Champion Homes
SKY
$4.97B
| $793K | ﹤0.01% |
10,681
-1,059
| -9% | -$66.6K |
|
1690
Amphastar Pharmaceuticals
AMPH
$915M
| $788K | ﹤0.01% |
12,744
-16,246
| -56% | -$853K |
|
1691
EverCommerce
EVCM
$1.69B
| $788K | ﹤0.01% |
71,402
-97,581
| -58% | -$941K |
|
1692
ATI
ATI
$28.6B
| $786K | ﹤0.01% |
17,289
-7,497
| -30% | -$311K |
|
1693
Simmons First National
SFNC
$3.32B
| $785K | ﹤0.01% |
39,572
-5,331
| -12% | -$89.2K |
|
1694
Onto Innovation
ONTO
$17.3B
| $785K | ﹤0.01% |
5,131
-3,407
| -40% | -$458K |
|
1695
Marathon Digital Holdings
MARA
$4.32B
| $783K | ﹤0.01% |
33,342
+16,385
| +97% | +$207K |
|
|
TEAD
1696
Teads Holding Co
TEAD
$59.8M
| $778K | ﹤0.01% |
177,674
-27,479
| -13% | -$116K |
|
|
GTY
1697
Getty Realty Corp
GTY
$2.07B
| $778K | ﹤0.01% |
26,616
+14,792
| +125% | +$419K |
|
1698
Lakeland Financial Corp
LKFN
$1.5B
| $776K | ﹤0.01% |
11,910
+3,388
| +40% | +$187K |
|
1699
Syndax Pharmaceuticals
SNDX
$1.75B
| $776K | ﹤0.01% |
35,902
+11,330
| +46% | +$174K |
|
|
HTO
1700
H2O America
HTO
$2.7B
| $774K | ﹤0.01% |
11,847
-980
| -8% | -$62.2K |
|
Similar funds
Cliff Asness's Q4 2023 Portfolio in Review
As of Q4 2023, Cliff Asness held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Cliff Asness's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Cliff Asness's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- Cliff Asness added most to Amazon in Q4 2023, an estimated $144M increase.
- Cliff Asness's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- Cliff Asness fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- Cliff Asness's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- Cliff Asness opened 186 new positions and closed 172 in Q4 2023.
- Cliff Asness's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.